Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 1/20 | 0.58 |
| ▸ | FBP1 | P09467 | 8/20 | 0.53 |
| ▸ | TLR4 | O00206 | 2/20 | 0.53 |
| ▸ | TLR2 | O60603 | 2/20 | 0.53 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.50 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.47 |
| ▸ | VCP | P55072 | 1/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.43 |
| ▸ | ATM | Q13315 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.43 |
| ▸ | CCR6 | P51684 | 1/20 | 0.43 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29742372 | 1.00 | RXRA (0.58) | RXRAFBP1TLR4TLR2HSD11B1 | |
| SCHEMBL2297149 | 1.00 | RXRA (0.58) | RXRAFBP1TLR4TLR2HSD11B1 | |
| SCHEMBL1805953 | 0.82 | RXRA (0.51) | RXRAFBP1TLR4TLR2PRMT1 | |
| SCHEMBL31627766 | 0.82 | RXRA (0.51) | RXRAFBP1TLR4TLR2PRMT1 | |
| SCHEMBL17533439 | 0.82 | RXRA (0.51) | RXRAFBP1TLR4TLR2PRMT1 | |
| SCHEMBL1805948 | 0.82 | RXRA (0.51) | RXRAFBP1TLR4TLR2PRMT1 | |
| SCHEMBL2118553 | 0.79 | RXRA (0.49) | RXRAFBP1TLR4TLR2PRMT1 | |
| SCHEMBL2118550 | 0.79 | RXRA (0.49) | RXRAFBP1TLR4TLR2PRMT1 | |
| SCHEMBL20562851 | 0.78 | RXRA (0.60) | RXRAFBP1TLR4TLR2PRMT1 | |
| SCHEMBL20562847 | 0.78 | RXRA (0.60) | RXRAFBP1TLR4TLR2PRMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0490567-A1 | The use of halogen-containing organic stabilizers for 3-isothiazolones | ROHM AND HAAS COMPANY (US) | 1992-06-17 | — | — | EP | claimed |
| JP-4217605-A | — | — | None | — | — | JP | disclosed |
| JP-3232802-A | — | — | None | — | — | JP | disclosed |
| US-20230159549-A1 | METHOD FOR PREPARATION OF ASENAPINE | ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. (CN) | 2023-05-25 | — | — | US | disclosed |
| US-11535628-B2 | Method for preparation of Asenapine | ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. (CN) | 2022-12-27 | — | — | US | disclosed |
| CN-113105401-B | 1, 2, 3-triazole derivative and preparation method and application thereof | 山东师范大学 | 2022-07-22 | — | — | CN | disclosed |
| EP-4015519-A1 | METHOD OF PREPARING ASENAPINE | Zhejiang Ausun Pharmaceutical Co., Ltd. (CN) | 2022-06-22 | — | — | EP | disclosed |
| CN-113105401-A | 1, 2, 3-triazole derivative and preparation method and application thereof | 山东师范大学 | 2021-07-13 | — | — | CN | disclosed |
| CN-112409408-A | Chiral phosphorus sulfur compound and Michael addition method thereof | 深圳湾实验室坪山生物医药研发转化中心 | 2021-02-26 | — | — | CN | disclosed |
| US-20210047339-A1 | METHOD FOR PREPARATION OF ASENAPINE | ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. (CN) | 2021-02-18 | — | — | US | disclosed |
| EP-1109745-A1 | METHOD AND COMPOSITION FOR INHIBITING GROWTH OF MICROORGANISMS INCLUDING PERACETIC ACID AND A NON-OXIDIZING BIOCIDE | NALCO CHEMICAL COMPANY (US) | 2001-06-27 | — | — | EP | disclosed |
| WO-1999065827-A1 | METHOD AND COMPOSITION FOR INHIBITING GROWTH OF MICROORGANISMS INCLUDING PERACETIC ACID AND A NON-OXIDIZING BIOCIDE | NALCO CHEMICAL COMPANY (US) | 1999-12-23 | — | — | WO | disclosed |
| EP-0487870-B1 | Insecticidal and acaricidal diarylpyrrolecarbonitrile and diarylnitropyrrole compounds | AMERICAN CYANAMID CO (US) | 1996-12-18 | — | — | EP | disclosed |
| US-5233052-A | Insecticidal and acaricidal diarylpyrrolecarbonitrile and diarylnitropyrrole compounds | AMERICAN CYANAMID COMPANY (US) | 1993-08-03 | — | — | US | disclosed |
| US-5180734-A | INSECTICIDAL AND ACARICIDAL DIARYLPYRROLECARBONITRILE AND DIARYLNITROPYRROLE COMPOUNDS | AMERICAN CYANAMID COMPANY (US) | 1993-01-19 | — | — | US | disclosed |
| US-5142058-A | For metal working fluids and latex paints | ROHM AND HAAS COMPANY (US) | 1992-08-25 | — | — | US | disclosed |
| JP-H04217605-A | ANTIBACTERIAL AND ANTIFUNGAL AGENT FOR INDUSTRIAL USE | KURITA WATER IND LTD | 1992-08-07 | — | — | JP | disclosed |
| EP-0490567-A1 | The use of halogen-containing organic stabilizers for 3-isothiazolones | ROHM AND HAAS COMPANY (US) | 1992-06-17 | — | — | EP | disclosed |
| EP-0487870-A2 | Insecticidal and acaricidal diarylpyrrolecarbonitrile and diarylnitropyrrole compounds | AMERICAN CYANAMID COMPANY (US) | 1992-06-03 | — | — | EP | disclosed |
| JP-H03232802-A | INDUSTRIAL GERMICIDE AND BACTERIOSTATIC AGENT | KATAYAMA CHEM WORKS CO LTD | 1991-10-16 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159549-A1 | METHOD FOR PREPARATION OF ASENAPINE | CYP3A5, QDPR, SPR | RXRA 4508/4885FBP1 3205/4885TLR4 4771/4885 |
| US-11535628-B2 | Method for preparation of Asenapine | CYP3A5, QDPR, SPR | RXRA 4508/4885FBP1 3205/4885TLR4 4771/4885 |
| US-20210047339-A1 | METHOD FOR PREPARATION OF ASENAPINE | CYP3A5, QDPR, SPR | RXRA 4508/4885FBP1 3205/4885TLR4 4771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.